Advertisement
Device Sectors
Subscribe to Device Sectors
View Sample

FREE Email Newsletter

Reportlinker Adds Endovascular Surgical Interventions: Technology Market Penetration and Roadmapping

June 20, 2011 3:38 am | by Bio-Medicine.Org | News | Comments

NEW YORK, June 20, 2011 /- Reportlinker.com announces that a new market research report is available in its catalogue: Endovascular Surgical Interventions: Technology Market Penetration and Roadmapping...

Pharma IQ's Pharma Distribution Survey report

June 19, 2011 11:44 pm | by Bio-Medicine.Org | News | Comments

LONDON, June 20, 2011 /- Pharma IQ has just published the results of an Industry-wide Pharmaceutical Distribution Survey, conducted recently among 3,000 pharmaceutical distribution specialist with over 83 % of those surveyed directly responsible for distribution at their respective...

NYT: Double CT Scans Unnecessary, Cost Medicare $25 million a year

June 19, 2011 8:37 am | by Diagnostic Imaging | News | Comments

Hundreds of hospitals across the country needlessly exposed patients to radiation by giving patients doubled-up CT chest scans a front page article in Saturday's New York Times found.

Advertisement

Dr. Seyed M. Rezaian's Spinal Fixator a Revolutionary Invention for Healing Injuries of the Thoracolumbar Spine

June 17, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

LOS ANGELES, June 17, 2011 /- Damage to the spine can happen for any number of reasons, whether it's a slip or fall, car accident, wear and tear from old age, or blunt injury. Unfortunately, people who have experienced back injury in the past have had to deal with back braces, reduced...

Franciscan St. Francis Heart Center Surgeon Pioneers Use of Heart Valve Repair Ring

June 17, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

INDIANAPOLIS, June 17, 2011 /- The St. Francis Heart Center  today (June 17, 2011) announced that it has performed the first post-FDA approval surgery in the United States using a new device for treating tricuspid valve disease. Called the Contour 3D™ Annuloplasty Ring, the...

Boston Scientific Innova Self-Expanding Stent System: Recall - Failure to Deploy(2)

June 17, 2011 11:31 am | by U.S. Food & Drug Administration | News | Comments

Failure may result in vessel wall injury, increased procedure time and/or emergency surgery to remove the partially deployed stent.

Unilife Hosts White House Business Council Meeting

June 17, 2011 9:34 am | by Bio-Medicine.Org | News | Comments

YORK, Pa., June 17, 2011 /- Unilife Corporation ("Unilife" or the "Company") (NASDAQ: UNIS ; ASX: UNS) today hosted Kathleen Merrigan, the Deputy Secretary of the U.S. Department of Agriculture, for a White House Business Council roundtable discussion with local business leaders at its...

Radiation Therapy Services Holdings, Inc. to Present at the Wells Fargo Securities 2011 Healthcare Conference

June 17, 2011 8:35 am | by Bio-Medicine.Org | News | Comments

FORT MYERS, Fla., June 17, 2011 /- Radiation Therapy Services Holdings, Inc. ("Radiation Therapy Services" or the "Company") today announced that its management team will present at the Wells Fargo Securities 2011 Healthcare Conference on Wednesday, June 22, 2011 at 10:15 a.m. Eastern...

Advertisement

Foundation Venture Capital Group Invests in Company Developing Plaque-Reducing Dental Hygiene Products

June 17, 2011 8:32 am | by Bio-Medicine.Org | News | Comments

NEW BRUNSWICK, N.J., June 17, 2011 /PRNewswire-USNewswire/ -- Affineti Biologics has received a commitment of up to $500,000 from Foundation Venture Capital Group (FVCG) to advance its research in the development of therapeutic and diagnostic products based on new discoveries in oral...

Zen Holding Corp. Changes Name to Millennium HealthCare Inc.

June 17, 2011 8:31 am | by Bio-Medicine.Org | News | Comments

SYOSSET, N.Y., June 17, 2011 /- Zen Holding Corp. (Symbol: ZNHL) today announced that the Board of Directors has approved a name change to Millennium HealthCare Inc.  The Company will be filing with the regulatory authorities for a symbol change as well. About Zen Holding Corp. Zen...

NewCardio to Present at Wells Fargo Securities Healthcare Conference

June 17, 2011 7:33 am | by Bio-Medicine.Org | News | Comments

SANTA CLARA, Calif., June 17, 2011 /- NewCardio, Inc., (OTC BB: NWCI) a cardiac diagnostic technology provider, announced today that Vincent Renz, Chief Executive Officer, is scheduled to present at the Wells Fargo Securities Healthcare Conference. The Conference is on June 22 and 23,...

Volcano Corporation Presentation at Wells Fargo Conference to be Webcast

June 17, 2011 7:32 am | by Bio-Medicine.Org | News | Comments

SAN DIEGO, June 17, 2011 /- Volcano Corporation (NASDAQ: VOLC ), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that it will be participating in...

Omthera Pharmaceuticals, Inc. to Present at the 2011 Wells Fargo Securities Healthcare Conference

June 17, 2011 6:33 am | by Bio-Medicine.Org | News | Comments

BEDMINSTER, N.J., June 17, 2011 /- Omthera Pharmaceuticals, Inc., a privately-held emerging specialty pharmaceuticals company, announced today that Jerry Wisler, President and Chief Executive Officer, will present at the 2011 Wells Fargo Securities Healthcare Conference at the...

Advertisement

ERT to Present at the 2011 Wells Fargo Securities Healthcare Conference on June 23, 2011

June 17, 2011 6:32 am | by Bio-Medicine.Org | News | Comments

PHILADELPHIA, June 17, 2011 /- ERT (NASDAQ: ERT ), announced today that Keith Schneck, the Company's Chief Financial Officer, is scheduled to present at the 2011 Wells Fargo Securities Healthcare Conference at 1:30 PM ET on Thursday, June 23, 2011 in Boston. Interested...

Positive Results From Avanafil Post-Prostatectomy Study Featured at Cancer Survivorship Meeting

June 17, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., June 17, 2011 /- VIVUS, Inc. (Nasdaq: VVUS ) today announced that the positive results from REVIVE-RP (TA-303), a phase 3 clinical trial evaluating the safety and efficacy of the investigational drug avanafil for the treatment of erectile dysfunction (ED),will be...

BioInformatics, LLC New Market Report - Life Science Instruments: Maximizing Market Share

June 17, 2011 4:36 am | by Bio-Medicine.Org | News | Comments

ARLINGTON, Va., June 17, 2011 /- BioInformatics, LLC announces the upcoming release of their newest market report:   Maximize Your Share of the Life Science Instrumentation Market (11-004) Available at pre-release pricing until July 15, 2011 To help instrumentation suppliers maximize...

Trading in Regeneron Common Stock Halted

June 17, 2011 4:35 am | by Bio-Medicine.Org | News | Comments

TARRYTOWN, N.Y., June 17, 2011 /- Regeneron Pharmaceuticals, Inc. (Nasdaq: REGN ) announced that NASDAQ has halted trading of the company's common stock today.  The Dermatologic and Ophthalmic Drugs Advisory Committee of the U.S. Food and Drug Administration (FDA) is meeting today to...

Novartis seeks vaccine approval for infants

June 17, 2011 1:34 am | by Mass High Tech: The Journal of New England Technology | News | Comments

The U.S. Food and Drug Administration is reviewing a vaccine for invasive meningococcal disease developed by Novartis Vaccines and Diagnostics, the Cambridge division of Switzerland-based Novartis, for accepted use in infants and toddlers from two months to two years old.

VGX Animal Health DNA Vaccine for Dogs Could Reduce Tumor Growth and Increase Survival

June 17, 2011 12:34 am | by Bio-Medicine.Org | News | Comments

BLUE BELL, Pa., June 17, 2011 /- Inovio Pharmaceuticals, Inc. (NYSE Amex: INO ) announced today that its subsidiary VGX Animal Health, Inc., a developer of DNA-based vaccines and therapies for companion and food animals, has achieved strong T cell responses from VAH-5000D, its DNA vaccine...

Chantix (varenicline): Label Change - Risk of Certain Cardiovascular Adverse Events

June 16, 2011 12:30 pm | by U.S. Food & Drug Administration | News | Comments

Results of a randomized, double-blind, placebo-controlled clinical trial of 700 smokers reviewed.

BioMedixâ„¢ Announces John Martin, MD, FACS, as Medical Director

June 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

SAINT PAUL, Minn., June 16, 2011 /- BioMedix™, a health IT company focused on improving lives through integrated medical devices and software, announces the appointment of John Martin, MD, FACS, as Medical Director. A respected researcher and author, Dr. Martin is one of the only...

Largest Acellular Dermal Allografts Available for Abdominal Wall Reconstruction Introduced at AWR 2011

June 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

WASHINGTON, June 16, 2011 /- The largest human dermal allograft available on the market today for hernia and abdominal wall repair will be introduced at the AWR meeting here this week.  The Musculoskeletal Transplant Foundation (MTF), the nation's leading tissue bank, is introducing...

Texas & U.S. Drug Treatment Gap to Be Highlighted at News Conference 11 a.m. June 23 By Former U.S. Drug Czar, U.S. Music Industry/Grammys Addiction Services Leader, Miss ...

June 16, 2011 11:36 am | by Bio-Medicine.Org | News | Comments

SAN ANTONIO, June 16, 2011 /PRNewswire-USNewswire/ -- The Texas and the U.S. drug treatment gap—nearly two million in Texas and 24 million nationwide who "need but do not receive" drug or alcohol treatment, according to the Substance Abuse and Mental Health Services Administration...

ThermoGenesis Announces Webcast of Presentation at OnemedForum Conference

June 16, 2011 11:34 am | by Bio-Medicine.Org | News | Comments

RANCHO CORDOVA, Calif., June 16, 2011 /- ThermoGenesis Corp. (NASDAQ: KOOL ), a leading supplier of innovative products and services that process and store adult stem cells, said today it will be participating in the OnemedForumNY 2011 Conference on Thursday, June 23. The presentation by...

Omnicell's OmniRx Automated Medication Dispensing System Receives 2011 Best in KLAS Award

June 16, 2011 11:33 am | by Bio-Medicine.Org | News | Comments

MOUNTAIN VIEW, Calif., June 16, 2011 /- Omnicell, Inc . (NASDAQ: OMCL ), a leading provider of medication and supply management solutions and analytics software for healthcare facilities, today announced the leading research firm, KLAS, has recognized Omnicell OmniRx ® automated...

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading